NCT04397991已完成不适用
Inhaled Furosemide for Transient Tachypnea of Newborn
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 64
- 试验地点
- 1
- 主要终点
- Percentage of patients with respiratory morbidity
研究概览
简要总结
This is a randomized double blind clinical trial in which newborns with suspected Transient tachypnea of the newborn (TTN) will receive either furosemide or normal saline by nebulizer every 6 hours for 24 hours.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 1 Day 至 1 Day（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Neonates with 34+0-39+0 gestational age
- •on the first day of life
- •with the clinical diagnosis of Transient Tachypnoea
- •need for CPAP >6 hours to obtain the oxygen saturation >92%
排除标准
- •Systemic infection
- •Intubation and mechanical ventilation before Inclusion in the trail
- •Malformation and any other disease with disturb of respiratory system
结局指标
主要结局
Percentage of patients with respiratory morbidity
时间窗: 24 hours
Neonatal respiratory morbidity will be assessed through oxygen saturation, respiratory rate and duration on Continuous positive airway pressure (CPAP)
次要结局
- Length of hospital stay(15 days)
研究者
Mariam Rajab
Principal Investigator
Makassed General Hospital
研究点 (1)
Loading locations...
相似试验
撤回
早期 1 期
Nebulized Furosemide in Premature Infants With Bronchopulmonary Dysplasia - A Cross Over Pilot Study of Its Efficacy and SafetyPremature InfantPremature BirthNCT03946891NYU Langone Health
已完成
4 期
3 Days Amoxicillin Versus Placebo for Fast Breathing Childhood Pneumonia in MalawiPneumoniaNCT02760420Save the Children1,126
招募中
不适用
Randomized Phase 2 Trial of Inhaled Furosemide on the dyspnea associated with CancerDyspnea associated with CancerJPRN-UMIN000005853Chiba University Hospital60
终止
2 期
Furosemide as Supportive Therapy for COVID-19 Respiratory FailureCovid19Respiratory FailureNCT04588792Dr. John Muscedere40
终止
2 期
SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.Respiratory Distress Syndrome, NewbornPremature BirthBronchopulmonary DysplasiaNCT00215540Windtree Therapeutics136